About Us

Overview

A leading incubator for cancer treatment innovations with a focus on the diagnosis and treatment of multiple myeloma, other B-cell malignancies and related disorders.

  • ONCOtracker, Inc. is a West Hollywood-based oncology company pursuing intellectual property for innovative treatments leading to dramatically improved outcomes.
  • We have exclusive rights to a Serum B-Cell Maturation Antigen (sBCMA) blood test, which is being developed to monitor tumor burden and predict the therapeutic outcome of multiple myeloma patients.
  • sBCMA is being investigated for clinical application in chronic lymphocytic leukemia, B-cell lymphoma and select solid tumor malignancies.
  • ONCOtracker has intellectual property related to novel treatment approaches for multiple myeloma, which are being pursued in ongoing clinical trials.

Leadership

James R. Berenson, MD

Founder
and Principal

About Dr. R. Berenson

Eric Souther, BSc

Director, Laboratory Operations
and Business Development

About Eric

Jessica Yataco

Jessica Yataco

Chief Operating Officer

About Jessica

Scientific Advisory Committee

O. Landgren, MD, PhD

Scientific Advisory
Committee Member

About Dr. Landgren

S. Lentzsch, MD, PhD

Scientific Advisory
Committee Member

About Dr. Lentzsch

R. Fonseca, MD, PhD

Scientific Advisory
Committee Member

About Dr. Fonseca

M. Albitar, MD, PhD

Scientific Advisory
Committee Member

About Dr. Albitar

Collaborations & Partnerships

How can we help you?